Product cited in:
Valenti, Canavesi, Galmozzi et al.: "Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease." in: Journal of hepatology, Vol. 53, Issue 5, pp. 927-33, 2010 (PubMed).
Neghina, Anghel: "Hemochromatosis genotypes and risk of iron overload--a meta-analysis." in: Annals of epidemiology, Vol. 21, Issue 1, pp. 1-14, 2010 (PubMed).
Schiepers, van Boxtel, de Groot et al.: "Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study." in: The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 65, Issue 12, pp. 1312-21, 2010 (PubMed).
Phatak, Brissot, Wurster et al.: "A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis." in: Hepatology (Baltimore, Md.), Vol. 52, Issue 5, pp. 1671-779, 2010 (PubMed).
Lehmann, Schuur, Warden et al.: "Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project." in: Neurobiology of aging, Vol. 33, Issue 1, pp. 202.e1-13, 2011 (PubMed).